Your browser doesn't support javascript.
loading
A review of cannabis allergy in the early days of legalization.
Toscano, Alessandro; Ebo, Didier G; Abbas, Khaldon; Brucker, Hannelore; Decuyper, Ine I; Naimi, David; Nanda, Anil; Nayak, Ajay P; Skypala, Isabel J; Sussman, Gordon; Zeiger, Joanna S; Silvers, William S.
Afiliação
  • Toscano A; Department of Immunology, Allergology, Rheumatology and the Infla-Med Centre of Excellence, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium; Immunology, Allergology, Rheumatology, Antwerp University Hospital, Antwerp, Belgium; Post-Graduate School of Allergology and
  • Ebo DG; Department of Immunology, Allergology, Rheumatology and the Infla-Med Centre of Excellence, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium; Immunology, Allergology, Rheumatology, Antwerp University Hospital, Antwerp, Belgium; Department of Immunology and Allergology
  • Abbas K; Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.
  • Brucker H; Southdale Allergy and Asthma Clinic, Minneapolis, Minnesota.
  • Decuyper II; Department of Pediatrics and the Infla-Med Centre of Excellence, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
  • Naimi D; Naval Hospital Camp Pendleton, Oceanside, California.
  • Nanda A; Asthma and Allergy Center, Lewisville and Flower Mound, Dallas, Texas; Division of Allergy and Immunology, The University of Texas Southwestern Medical Center, Dallas, Texas.
  • Nayak AP; Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Skypala IJ; Royal Brompton & Harefield Hospitals, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
  • Sussman G; Department of Medicine and Division of Clinical Immunology & Allergy, University of Toronto, Toronto, Ontario, Canada.
  • Zeiger JS; Canna Research Foundation, Boulder, Colorado.
  • Silvers WS; University of Colorado School of Medicine, Denver, Colorado.
Ann Allergy Asthma Immunol ; 130(3): 288-295, 2023 03.
Article em En | MEDLINE | ID: mdl-36384984
ABSTRACT
Cannabis allergy is a burgeoning field; consequently, research is still in its infancy and allergists' knowledge surrounding this topic is limited. As cannabis legalization expands across the world, it is anticipated that there will be an increase in cannabis use. Thus, we hypothesize that a concomitant rise in the incidence of allergy to this plant can be expected. Initiatives aimed at properly educating health care professionals are therefore necessary. This review presents the most up-to-date information on a broad range of topics related to cannabis allergy. Although the clinical features of cannabis allergy are becoming more well described and recognized, the tools available to make a correct diagnosis are meager and often poorly accessible. In addition, research on cannabis allergy is still taking its first steps, and new and potentially groundbreaking findings in this field are expected to occur in the next few years. Finally, although therapeutic approaches are being developed, patient and physician education regarding cannabis allergy is certainly needed.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Médicos / Cannabis / Hipersensibilidade Limite: Humans Idioma: En Revista: Ann Allergy Asthma Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Médicos / Cannabis / Hipersensibilidade Limite: Humans Idioma: En Revista: Ann Allergy Asthma Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2023 Tipo de documento: Article